Women’s health CDMO in Europe for sale

Company for sale

• Size: Medium
• Revenue: > 20 million EUR
• Location: Europe
• Suitable for: Financial and strategic investors
• CFIE PHS183

Overview of women’s health CDMO in Europe for sale

Founded as a European biotech enterprise, this company is dedicated to transforming women’s health by introducing innovative choices. Particularly, in the areas of contraception and menopause. Essentially, the goal is to develop products that offer superior efficacy, safety, and convenience. Thus, catering to women’s needs throughout their lives. With a focus on the unique native estrogen estetrol, the company launched its first estetrol-based product in 2021. Now, it is concentrating on its second product, a next-generation hormone therapy.

Profile of women’s health CDMO in Europe for sale

Overall, this company has made significant strides in women’s health by leveraging the potential of estetrol across a broad range of applications. Altogether, it develops and manufactures complex therapeutics in contraception, menopause, and hormone-dependent cancers. Further, the company operates a comprehensive technological platform that offers research, development, and specialist manufacturing services. With a presence in over 100 countries, the company is a global player in its field.

Activities and products of women’s health CDMO in Europe for sale

In total, the company’s activities span the full spectrum of pharmaceutical development to commercial manufacturing. Specifically, it specializes in sterile injectables and polymeric forms. Notably, it offers a wide array of services including pharmaceutical development, clinical supply manufacturing, stability studies, and contract manufacturing. Moreover, logistics, supply chain management, quality assurance, and regulatory support. Their product portfolio includes:

• Estelle®: The first estetrol-based contraceptive pill
• Donesta®: The next-generation hormone therapy in development
• Complex therapeutics: Products for contraception, menopause, and hormone-dependent cancers
• End-to-end services: An integrated platform providing end-to-end services from pharmaceutical development to commercial manufacturing

Highlights of women’s health CDMO in Europe for sale

• Mission: To offer innovative and effective solutions for women’s health, particularly in contraception and menopause
• R&D and innovation: Continually pushing the boundaries of women’s health with products based on estetrol
• Global presence: Active in more than 100 countries with a workforce of around 300 employees
• State-of-the-art platform: Supports the full range of pharmaceutical development and manufacturing services
• Facilities and capabilities:
  • 15,000 m² facility
  • Three industrial production units for polymeric forms, sterile injectables, and hormonal tablets
  • Compliance with GMP standards (EMA/FDA)
  • Capability to handle special and highly potent drug products
• Comprehensive services: From pilot to commercial batch sizes, offering flexibility and state-of-the-art equipment
• Strategic expansion: Continues to develop late-stage products and new products in women’s health

More information on this women’s health CDMO in Europe for sale

Please get in touch if you are interested in learning more about this women’s health CDMO in Europe for sale. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.